Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 3:33 p.m.

    📋 PROMETHEUS BIOSCIENCES, INC. (RXDX) - Financial Results

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 16:02:23

    Event Type: Financial Results

    Event Details:

    Prometheus Biosciences Inc (company is now a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the United States and Canada) (RXDX) Reports Q2 2022 Financial Results Prometheus Biosciences Inc (company is now a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the United States and Canada) (RXDX) announced its financial results for the period ending Q2 2022. Key Financial Highlights:
    • Revenue: 3919
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 227034
      • expected in 4Q • Topline results from APOLLO-CD Phase 2a study expected in 4Q First Quarter 2022
      • planned for 3Q • Topline results from the ARTEMIS-UC Phase 2 study expected in 4Q • Topline results from APOLLO-CD Phase 2a study expected in 4Q First Quarter 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Loss From Operations 32.10K 12.22K $19.88K +162.65%
    Operating Expenses Total Other Income Expense 30.00 1.73K $-1.70K -98.26%
    Operating Expenses Net Loss 32.07K 13.95K $18.12K +129.95%
    Operating Expenses Net Loss Per Share 0.82 1.67 $-0.85 -50.90%
    Assets Other Assets 18.60K 2.42K $16.18K +669.11%
    Revenue 3.92K 760.00 $3.16K +415.66%
    Loss from Operations 32.10K 12.22K $19.88K +162.65%
    Net Loss 32.07K 13.95K $18.12K +129.95%
    Other Assets 18.60K 2.42K $16.18K +669.11%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Prometheus Biosciences Inc (company is now a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside the United States and Canada)
    • CIK: 0001718852
    • Ticker Symbol: RXDX
    • Period End Date: 2022-05-12
    • Document Type: 8-K

Search

News categories